Home > PJ (current issue) > The Society / News Centre | Search

The Pharmaceutical Journal
Vol 274 No 7353 p715
11 June 2005


Society summary


Unified banking scheme for branch bank accounts

The branches of the Royal Pharmaceutical Society will soon be able to benefit from higher interest rates on their bank accounts under a unified banking scheme.

The scheme has been recommended by the Society’s internal auditors as part of the process of moving all Society accounts into the Society’s banking accounts with NatWest, which is part of the Royal Bank of Scotland Group, to improve corporate governance. Branches will be free to choose any local NatWest or RBS branch to hold their accounts and to make any local arrangements for services.

The scheme will begin to be rolled out in July. The process is expected to be completed by the end of 2005.

Unified banking has already been tested and approved by the nine branches taking part in the Society’s “Future branch” pilot.

Under the scheme, branches will receive a higher than usual rate of interest paid to a special interest bearing account (SIBA). NatWest will provide a special arrangement allowing them to maintain day-to-day control of their funds on both a current account and a SIBA.

The SIBA will pay an interest rate of bank base rate less 0.5 per cent. At present this is 3.5 per cent.

Back to Top


©The Pharmaceutical Journal